| Dr Frank David Denunzio, DDS | |
|
2901 E Katella Ave, Suite B, Orange, CA 92867-5248 | |
| (714) 274-5461 | |
| (714) 242-9509 |
| Full Name | Dr Frank David Denunzio |
|---|---|
| Gender | Male |
| Speciality | Dentist |
| Location | 2901 E Katella Ave, Orange, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336359793 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 16498 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Frank David Denunzio, DDS 2901 E Katella Ave, Suite B, Orange, CA 92867-5248 Ph: (714) 274-5461 | Dr Frank David Denunzio, DDS 2901 E Katella Ave, Suite B, Orange, CA 92867-5248 Ph: (714) 274-5461 |
News Archive
In a study published in Molecular Metabolism, a SLU researcher has found that adropin, a hormone that regulates whether the body burns fat or sugar during feeding and fasting cycles, can improve insulin action in obese, diabetic mice, suggesting that it may work as a therapy for type 2 diabetes.
Avedro, Inc. announced today that the Company submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for its VibeX (riboflavin ophthalmic solution) /KXL System for the treatment of keratoconus and corneal ectasia following refractive surgery.
URAC announced today that a distinguished panel of judges has selected 30 finalists for its Best Practices in Health Care Consumer Empowerment and Protection Awards. The competition drew entries from across the nation. The finalists will be honored during URAC's 11th Annual Quality Summit, October 5-7, 2010 in Chicago, IL. The awards honor programs in two areas: Consumer Decision-Making and Consumer Health Improvement.
Celator Pharmaceuticals today announced that interim safety and efficacy data from its Phase 2 multicenter, randomized, open-label clinical trial of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection versus conventional cytarabine and daunorubicin therapy ("7+3") in patients 60-75 years of age with untreated acute myeloid leukemia (AML) were presented at the 51st American Society of Hematology (ASH) Annual Meeting in New Orleans, Louisiana (ASH Abstract # 1033).
Public health agencies across the UK should launch a National Covid-19 Resilience Programme to support older people through the pandemic and to keep them healthy and resilient over the winter - that's the recommendation from a leading group of scientists and clinicians working in the fields of physiology, nutrition and physiotherapy.
› Verified 1 days ago
Dr. Steven D Ogaz, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 4122 E Chapman Ave Ste 1, Orange, CA 92869 Phone: 714-639-9171 Fax: 714-639-2096 | |
Noor Khedraki, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 530 S Main St, Orange, CA 92868 Phone: 714-571-3682 | |
Dr. Gerald M Turk, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1122 E Lincoln Ave Ste 208, Orange, CA 92865 Phone: 714-921-2110 Fax: 714-974-0442 | |
Dr. Scott M Nishizaka, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 900 E Katella Ave, Suite A, Orange, CA 92867 Phone: 714-538-2811 Fax: 714-538-5911 | |
Dr. Louis James Amendola, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 530 S Main St, Orange, CA 92868 Phone: 714-571-3603 | |
Dr. Kazu Takaki, Dentist Medicare: Not Enrolled in Medicare Practice Location: 530 S Main St, Orange, CA 92868 Phone: 714-480-3000 Fax: 714-571-3560 | |
Patrick Tadashi Yoshikane, DDS Dentist Medicare: Medicare Enrolled Practice Location: 845 W La Veta Ave Ste 103, Orange, CA 92868 Phone: 714-516-1600 Fax: 714-516-1592 |